Ondansetron 8 mg ODFS without water
OND/CR/051/08/09
Phase 1 small_molecule completed
Quick answer
Ondansetron 8 mg ODFS without water for Healthy Participants is a Phase 1 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aquestive Therapeutics
- Indication
- Healthy Participants
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed